Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or theP-glycoprotein
C. Marbeuf-gueye et al., Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or theP-glycoprotein, BBA-MOL CEL, 1450(3), 1999, pp. 374-384
Citations number
29
Categorie Soggetti
Cell & Developmental Biology
Journal title
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Multidrug resistance (MDR) in model systems is known to be conferred by two
different integral proteins, the 170-kDa P-glycoprotein (Pgp) and the 190-
kDa multidrug resistance associated protein (MRP1). One possible pharmacolo
gical approach to overcome drug resistance is the use of specific inhibitor
s, which enhance the cytotoxicity of known antineoplastic agents. However,
while many compounds have been proven to be very efficient in inhibiting Pg
p activity only some of them are able to inhibit MRP1. The other Likely app
roach is based on the design and synthesis of new non-cross-resistant drugs
with physicochemical properties favoring the uptake of the drug by the res
istant cells. The intracellular drug retention influences its cytotoxic eff
ect. The level of the intracellular drug content is a function of the amoun
t of drug transported inside the cell (influx) and the amount of drug expel
led from the cell (efflux). In this work, the kinetics of drug uptake and t
he kinetics of active efflux of several anthracycline derivatives in both P
gp expressing K562/Adr cells and MRP1 expressing GLC4/Adr cells was determi
ned. Our data have shown that in both cell lines there is no correlation be
tween the resistance Factor and the kinetics of drug efflux by these pumpin
g systems. However, a very good correlation between the resistance factor a
nd the kinetics of drug uptake has been established in both cell lines: the
resistance factor decreases when the kinetics of drug uptake increases; Th
is work has clearly shown that when the rate of transmembrane transport of
anthracycline is high enough, the efflux mediated by the protein transporte
r is not able to pace with it. The protein transporter essentially operates
in a futile cycle and the resistance factor is tending to one. It does not
mean, however, that when the resistance factor is close to one the anthrac
ycline is not transported by the pump. (C) 1999 Elsevier Science B.V. All r
ights reserved.